Danish pharmaceutical giant Novo Nordisk has revised its profit forecasts downwards for the fourth time this year as competition in the slimming and diabetes treatments market continues to grow. The
All posts tagged in wegovy
7Articles
Weight loss injections have rapidly transformed the British approach to tackling obesity, with an extraordinary surge in private usage. Latest data suggests that 2.5 million adults in the UK—one in
Eli Lilly, the pharmaceutical giant behind the popular weight loss injection Mounjaro, has announced a substantial price hike for the medication due to take effect in the UK from September.
Shares in Novo Nordisk climbed over five per cent on the Copenhagen exchange after the Danish pharmaceuticals firm received crucial approval from the United States Food and Drug Administration for
Novo Nordisk, the Danish pharmaceutical titan known for its diabetes and weight loss treatments Ozempic and Wegovy, now faces a period of significant turbulence. The company has issued a stark
Denmark’s Novo Nordisk has adjusted its annual revenue and profit forecasts downward following weaker-than-expected sales of its weight-loss drug Wegovy in the United States. The company, which became Europe’s most
Danish pharmaceutical giant Novo Nordisk has reported exceptional third-quarter results, driven by remarkable sales of its weight-loss treatment Wegovy. The anti-obesity medication generated sales of 17.3 billion Danish krone (£1.96
